9DQL
human ClpP - Bortezomib - A192E / E196R
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CLSI BEAMLINE 08ID-1 |
Synchrotron site | CLSI |
Beamline | 08ID-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-11-23 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 0.95358 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 122.190, 93.880, 133.720 |
Unit cell angles | 90.00, 97.87, 90.00 |
Refinement procedure
Resolution | 44.240 - 3.200 |
R-factor | 0.1877 |
Rwork | 0.186 |
R-free | 0.23680 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.003 |
RMSD bond angle | 0.521 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 48.080 | 3.090 |
High resolution limit [Å] | 3.030 | 3.030 |
Number of reflections | 114141 | 3791 |
<I/σ(I)> | 8.9 | 0.67 |
Completeness [%] | 99.8 | |
Redundancy | 6.8 | |
CC(1/2) | 0.998 | 0.246 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 295 | 200 mM potassium acetate, 35% (v/v) pentaerythritol propoxylate (5/4 PO/OH) |